Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and ...
Historically, much of the research conducted in our 'Heart Lab' has been at the interface of medicine and engineering, dedicated to the discovery and development of innovative methodologies (molecular ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
A tool like a tiny orbital sander is the heart of the Diamondback 360° system, a medical device that removes plaque from the walls of arteries in the leg. It’s the flagship product of Cardiovascular ...
Cardiovascular disease is the leading cause of death in the United States, claiming an estimated 1 million lives, and incurring a cost of $400 billion per year. Much of cardiovascular disease can be ...
Cellular biomechanics of neural and vascular injury, mechanotransduction in the cardiovascular system, mechanical control of growth and development for wound healing and tissue engineering Engineering ...
Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results